Published in Arch Ophthalmol on February 01, 1993
The Diagnosis and Treatment of Optic Neuritis. Dtsch Arztebl Int (2015) 2.21
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm (2014) 1.29
Retinal nerve fiber layer thickness in nonarteritic anterior ischemic optic neuropathy: OCT characterization of the acute and resolving phases. Graefes Arch Clin Exp Ophthalmol (2008) 1.23
Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol (2010) 1.10
Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial. BMC Ophthalmol (2006) 1.03
Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol (2010) 1.01
Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study. Trans Am Ophthalmol Soc (2006) 1.00
Visual recovery following acute optic neuritis--a clinical, electrophysiological and magnetic resonance imaging study. J Neurol (2004) 0.99
Use of a portable head mounted perimetry system to assess bedside visual fields. Br J Ophthalmol (2000) 0.98
Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up. Trans Am Ophthalmol Soc (2004) 0.94
Visual fields in neuro-ophthalmology. Indian J Ophthalmol (2011) 0.91
Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci (2014) 0.87
Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study. PLoS One (2012) 0.87
Visual field defects in acute optic neuritis--distribution of different types of defect pattern, assessed with threshold-related supraliminal perimetry, ensuring high spatial resolution. Graefes Arch Clin Exp Ophthalmol (2008) 0.86
Comparison of optical coherence tomography and scanning laser polarimetry measurements in patients with multiple sclerosis. Optom Vis Sci (2010) 0.80
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy. Indian J Ophthalmol (2014) 0.79
Symptomatic therapy in multiple sclerosis. Ther Adv Neurol Disord (2011) 0.79
Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev (2015) 0.79
Variation of visual evoked potential delay to stimulation of central, nasal, and temporal regions of the macula in optic neuritis. J Neurol Neurosurg Psychiatry (2001) 0.78
Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy. Clin Ophthalmol (2017) 0.77
A retrospective analysis of characteristics of visual field damage in patients with Leber's hereditary optic neuropathy. Springerplus (2016) 0.77
Ultrasonography in distinguishing optic neuritis from nonarteritic anterior ischemic optic neuropathy. Adv Biomed Res (2012) 0.77
Investigation of visual loss: neuro-ophthalmology from a neurologist's perspective. J Neurol Neurosurg Psychiatry (1996) 0.75
Chronic Invasive Fungal Sinusitis Presenting as Inferior Altitudinal Visual Field Defect. Neuroophthalmology (2017) 0.75
Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci (2016) 0.75
Visual fields in optic neuritis. Arch Ophthalmol (1993) 0.75
Patients' knowledge and perception on optic neuritis management before and after an information session. BMC Ophthalmol (2010) 0.75
[Current recommendations on optic neuritis]. Ophthalmologe (2014) 0.75
The value of visual field testing in the era of advanced imaging: clinical and psychophysical perspectives. Clin Exp Optom (2017) 0.75
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Does Levodopa improve visual function in NAION? Ophthalmology (2000) 9.70
Screening depressed patients in family practice. A rapid technic. Postgrad Med (1972) 5.89
Mediating mechanisms in a school-based drug prevention program: first-year effects of the Midwestern Prevention Project. Health Psychol (1991) 5.85
The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol (2001) 5.78
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet (1999) 5.61
Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol. Am J Ophthalmol (2001) 5.37
A multicommunity trial for primary prevention of adolescent drug abuse. Effects on drug use prevalence. JAMA (1989) 5.31
The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother (1968) 4.75
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med (2000) 4.50
Surveillance for asthma--United States, 1960-1995. MMWR CDC Surveill Summ (1998) 3.82
Measurement of adolescent smoking behavior: rationale and methods. J Behav Med (1984) 3.70
The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology (1999) 3.23
Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group. Neurology (1992) 3.19
Saliva thiocyanate: a chemical indicator of cigarette smoking in adolescents. Am J Public Health (1981) 2.88
English language use as a risk factor for smoking initiation among Hispanic and Asian American adolescents: evidence for mediation by tobacco-related beliefs and social norms. Health Psychol (2000) 2.36
Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med (1994) 2.13
Stability of blood in commonly used anticoagulants. Use of refrigerated blood for quality control of the Coulter Counter Model S. Am J Clin Pathol (1969) 2.07
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol (1999) 2.05
Predicting binocular visual field sensitivity from monocular visual field results. Invest Ophthalmol Vis Sci (2000) 2.04
Reliability of self-report measures of drug use in prevention research: evaluation of the Project SMART questionnaire via the test-retest reliability matrix. J Drug Educ (1984) 1.97
Attrition in prevention research. J Behav Med (1985) 1.96
Smoking patterns of Asian-American youth in California and their relationship with acculturation. J Adolesc Health (1999) 1.90
Recognition and liking of tobacco and alcohol advertisements among adolescents: relationships with susceptibility to substance use. Prev Med (1995) 1.88
Incidence of visual field loss in 20,000 eyes and its relationship to driving performance. Arch Ophthalmol (1983) 1.88
Recent advances in the molecular pathology, cell biology and genetics of ciliopathies. J Med Genet (2008) 1.84
Optimum parameters for short-wavelength automated perimetry. J Glaucoma (1996) 1.84
Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol (2000) 1.83
Affective and social influences approaches to the prevention of multiple substance abuse among seventh grade students: results from project SMART. Prev Med (1988) 1.82
Prevention of cigarette smoking in seventh grade students. J Behav Med (1980) 1.78
Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology (1984) 1.74
Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Pediatr Pulmonol (1998) 1.73
The Amblyopia Treatment Index. J AAPOS (2001) 1.68
Test-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects. Invest Ophthalmol Vis Sci (1999) 1.68
Studies on glycopeptides released by trypsin from intact human erythrocytes. Biochemistry (1967) 1.67
Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients. Am J Ophthalmol (2001) 1.66
A clinical comparison of visual field testing with a new automated perimeter, the Humphrey Field Analyzer, and the Goldmann perimeter. Ophthalmology (1985) 1.64
Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol (2000) 1.62
The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci (2000) 1.61
Identification of a conserved erythroid specific domain of histone acetylation across the alpha-globin gene cluster. Proc Natl Acad Sci U S A (2001) 1.57
Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome. Neurology (2007) 1.56
DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol (2001) 1.55
Cross-validation of the Suicidal Intent Scale. Psychol Rep (1974) 1.54
Prevention of cigarette smoking: three-year follow-up of an education program for youth. J Behav Med (1983) 1.52
Dural and carotid cavernous sinus fistulas. Diagnosis, management, and complications. Ophthalmology (1987) 1.51
Cortical blindness: etiology, diagnosis, and prognosis. Ann Neurol (1987) 1.51
Effects of a community-based prevention program on decreasing drug use in high-risk adolescents. Am J Public Health (1998) 1.50
The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs. Headache (1992) 1.50
Observational study of subclinical diabetic macular edema. Eye (Lond) (2012) 1.49
Response properties of normal observers and patients during automated perimetry. Arch Ophthalmol (1989) 1.45
Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J Med Genet (2002) 1.44
Regulation of the cytoplasmic accumulation of 5-methyltetrahydrofolate in MA104 cells is independent of folate receptor regulation. J Clin Invest (1989) 1.44
Neuroretinitis in childhood. J Pediatr Ophthalmol Strabismus (1989) 1.43
Variability components of standard automated perimetry and frequency-doubling technology perimetry. Invest Ophthalmol Vis Sci (2001) 1.42
Independent evaluation of the California Tobacco Education Program. Public Health Rep (1996) 1.40
Using parents as change agents for their children: a review. J Child Psychol Psychiatry (1973) 1.40
Anorexia nervosa: an overview. Am Fam Physician (1996) 1.39
Von Willebrand's disease: a comparative study of diagnostic tests. J Pediatr (1968) 1.39
Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol (1998) 1.39
Teaching family-centered perinatal care in family medicine, Part 2. Fam Med (1992) 1.37
Is acculturation a risk factor for early smoking initiation among Chinese American minors? A comparative perspective. Tob Control (1999) 1.35
The natural history of acute traumatic sixth nerve palsy or paresis. J AAPOS (1998) 1.34
Tailoring outdoor tobacco advertising to minorities in Los Angeles County. J Health Commun (2000) 1.34
Visual field damage in normal-tension and high-tension glaucoma. Am J Ophthalmol (1989) 1.34
Is there a racial difference in physiologic cup size? Ophthalmology (1985) 1.33
Effects of target size and eccentricity on visual detection and resolution. Vision Res (1978) 1.33
Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. Pediatrics (1998) 1.33
Ethnic variation in peer influences on adolescent smoking. Nicotine Tob Res (2001) 1.33
Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Am J Ophthalmol (1996) 1.31
Psychosocial predictors of cigarette smoking onset by white, black, Hispanic, and Asian adolescents in Southern California. MMWR Morb Mortal Wkly Rep (1987) 1.30
Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol (1999) 1.29
Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. JAMA (1993) 1.28
Identification of adolescents at risk for smoking initiation: validation of a measure of susceptibility. Addict Behav (1997) 1.28
Senescent changes of the normal visual field: an age-old problem. Optom Vis Sci (2001) 1.25
dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster. Exp Cell Res (2001) 1.24
The Minnesota smoking prevention program: a seventh-grade health curriculum supplement. J Sch Health (1981) 1.24
Surveillance for dust storms and respiratory diseases in Washington State, 1991. Arch Environ Health (1994) 1.23
Functional decline in the elderly: evidence for direct and stress-buffering protective effects of social interactions and physical activity. Ann Behav Med (1997) 1.23
The consistency of peer and parent influences on tobacco, alcohol, and marijuana use among young adolescents. J Behav Med (1987) 1.23
Performance characteristics of the 3-D OSEM algorithm in the reconstruction of small animal PET images. Ordered-subsets expectation-maximixation. IEEE Trans Med Imaging (2000) 1.22
Substance use among eighth-grade students who take care of themselves after school. Pediatrics (1989) 1.20
Visual function and driving safety. Arch Ophthalmol (1992) 1.20
Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion (1996) 1.19
Orbital emphysema as an ophthalmologic emergency. Ophthalmology (1984) 1.17
Deficits in visual function after resolution of optic neuritis. Ophthalmology (1987) 1.16
Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem (1998) 1.16
Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol (1987) 1.16
Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal Biochem (1999) 1.15
Bilateral idiopathic inflammation of the optic nerve sheaths. Light and electron microscopic findings. Ophthalmology (1989) 1.15
Exposure to methyl tertiary-butyl ether from oxygenated gasoline in Stamford, Connecticut. Arch Environ Health (1995) 1.15
Hazard of smoking initiation by age among adolescents in Wuhan, China. Prev Med (2001) 1.15
Quantitative relation between emphysema and lung mineral content in coalworkers. Occup Environ Med (1994) 1.15
Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol (1994) 1.14
The television school and family smoking prevention and cessation project. 1. Theoretical basis and program development. Prev Med (1988) 1.14
Comparison of central and peripheral visual field properties in the optic neuritis treatment trial. Am J Ophthalmol (1999) 1.13